Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells

Inclusion Criteria: * Ability to provide written informed consent * Mentally stable and able to comply with the procedures of the study protocol * Clinical history compatible with type 1 diabetes diagnosed less than 10 days of enrolment Stimulate c-peptide \>0.1 nmol/l Exclusion Criteria: * Patients with BMI\>30 * Patients with unstable cardiovascular status * Patients with active infections, unless treatment is not judged necessary by the investigators * Patients with serological evidence of infection with HIV, hepatitis B or hepatitis C. * Sexually active females who are not a) postmenopausal, b) surgically sterile or c) using an acceptable method of contraception: oral contraceptives, Norplant, Depo-provera and barrier devices combined with spermicidal gel are acceptable. * Patients with known or previous malignancy. Patient with any condition or any circumstance that in the opinion of the investigator would make it unsafe to undergo treatment with autologous MSC.